Relying on one giant AI model for everything is a trap; it’s too expensive and slow for simple tasks and too risky for the ...
While evaluating the impact of AI on the labor market is complex, we can distill both optimistic and pessimistic views into ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
The market overvalues AGI as LLMs plateau, but BRK.A and UNH leverage AI for gains while others face bubble risks. Find out ...
Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Eric's career includes extensive work in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results